Recent Evenity Market Analysis by The Business Research Company Highlights Upcoming Industry Trends and Projections

The Business Research Company

Recent Evenity market

LONDON, GREATER LONDON, UNITED KINGDOM, November 4, 2026 /EINPresswire.com/ -- The Evenity market is gaining significant attention as more people worldwide face osteoporosis, especially postmenopausal women at risk for fractures. With advancements in treatment options and increasing awareness of bone health, this market is poised for steady growth. Let’s explore the market’s current size, key factors behind its expansion, and the regions leading this upward trend.

Market Size and Growth Outlook for the Evenity Market
Historically, the Evenity market’s growth has been fueled by an aging female population, widespread cases of postmenopausal osteoporosis, and the limitations presented by antiresorptive drugs. Additionally, increased complications from fractures and early successes with biologic bone therapies have supported market expansion. Looking ahead, the forecast period growth can be attributed to rising awareness about bone health, enhanced osteoporosis screening, broader adoption of biologic treatments, improved healthcare access for the elderly, and favorable reimbursement policies promoting fracture prevention. Trends shaping this future also include increased use of anabolic osteoporosis therapies, greater emphasis on reducing fracture risk, preference for monthly injectable treatments, shorter but highly effective osteoporosis regimens, and integration of biologics in comprehensive bone care.

Download a free sample of the evenity market report:
https://thebusinessresearchcompany.com/sample_request?id=74762355&type=smp&name=Evenity%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Oct_PR

Understanding Evenity and Its Role in Osteoporosis Treatment
Evenity (romosozumab) is a biologic drug specifically designed to treat osteoporosis in postmenopausal women who are at high risk of fractures. The medication works by blocking sclerostin, which helps stimulate new bone formation while also decreasing bone loss. It is typically administered as a monthly subcutaneous injection for up to 12 months, after which patients usually transition to other osteoporosis therapies to maintain bone health.

Primary Factors Driving Growth in the Evenity Market
One of the main drivers propelling the Evenity market forward is the increasing prevalence of osteoporosis. This condition leads to reduced bone density and quality, making bones fragile and more susceptible to fractures. The rise in osteoporosis cases is largely linked to an aging population experiencing naturally declining bone mass, along with sedentary lifestyles that weaken bone strength. Evenity’s monthly injections work to enhance bone formation, limit bone breakdown, and strengthen the skeletal system to prevent fractures. For example, in February 2023, the UK's Royal Osteoporosis Society reported that fragility fractures cost the National Health Service (NHS) approximately $5.89 billion each year, with hip fractures alone accounting for $2.62 billion. This highlights the substantial impact of osteoporosis and supports the growing demand for treatments like Evenity.

View the full evenity market report:
https://thebusinessresearchcompany.com/report/evenity-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Oct_PR

Increasing Drug Approvals Supporting Market Expansion
The growing number of drug approvals represents another key factor supporting the Evenity market’s progression. Regulatory agencies are increasingly authorizing new pharmaceutical products thanks to advances in biotechnology and streamlined approval processes, such as accelerated programs designed for urgently needed therapies. These approvals boost the availability of innovative treatments, improve patient access, and build confidence among healthcare professionals. For instance, in July 2024, the American Society of Gene and Cell Therapy (ASGCT) reported a 25% increase in gene therapy trials initiated during the second quarter of 2024 compared to the previous quarter, reflecting the rapid pace of innovation. Such developments are directly contributing to the expansion of markets like Evenity.

The Role of Rising Healthcare Spending in Market Growth
Healthcare expenditure is another important factor influencing the Evenity market’s growth trajectory. This spending includes funds allocated to medical services, prevention, medications, and health infrastructure, all aimed at improving population health. Rising costs are driven by an aging population requiring more medical care, as well as technological advancements that raise treatment expenses. For Evenity, increased healthcare expenditure means better coverage of medication costs, enhanced healthcare services, and improved access to osteoporosis therapies for older adults. According to the UK’s Office for National Statistics in May 2024, healthcare spending rose by 5.6% in nominal terms from 2022 to 2023, a significant increase compared to the 0.9% growth seen in 2022, underscoring growing investment in health resources.

Leading Regions in the Evenity Market Landscape
When it comes to geographic dominance, North America held the largest share of the Evenity market in 2025, reflecting high demand and well-established healthcare infrastructure. Meanwhile, Europe is projected to experience the fastest market growth during the forecast period, driven by increasing awareness and healthcare improvements. The Evenity market report also covers other key regions including Asia-Pacific, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a comprehensive global view of market trends and opportunities.

Key enhancements in our 2026 market reports include:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X